ZHEJIANG RUIBANG LABORATORIES INC
Overview
ZHEJIANG RUIBANG LABORATORIES INC is an active pharmaceutical ingredient (API) supplier with 3 active FDA Type II Drug Master Files, covering CALCIUM GLUCONATE FOR INJECTION; CYCLOSPORINE; THIOSTREPTON USP (NON-STERILE BULK FORM).
API / Drug Master Files
ZHEJIANG RUIBANG LABORATORIES INC holds 3 active (8 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- CALCIUM GLUCONATE FOR INJECTIONActive2021-06-01
- CYCLOSPORINEActive2014-12-03
- THIOSTREPTON USP (NON-STERILE BULK FORM)Active2000-11-22
- CYCLOSPORINE CRUDEInactive2018-03-05
- LOVASTATIN USPInactive2005-03-15
- SIMVASTATIN USPInactive2005-01-25
- CYCLOSPORINEInactive1998-11-23
- LOVASTATINInactive1997-03-02
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to ZHEJIANG RUIBANG LABORATORIES INC in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.